User profiles for Todd C. Lee
Todd C. Lee MD MPH FIDSAAssociate Professor, McGill University, Montreal QC Verified email at mcgill.ca Cited by 9736 |
[HTML][HTML] A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
[HTML][HTML] Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
Background: The role of remdesivir in the treatment of patients in hospital with COVID-19
remains ill defined in a global context. The World Health Organization Solidarity randomized …
remains ill defined in a global context. The World Health Organization Solidarity randomized …
Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis
Importance Nasopharyngeal swab nucleic acid amplification testing (NAAT) is the noninvasive
criterion standard for diagnosis of coronavirus disease 2019 (COVID-19). However, it …
criterion standard for diagnosis of coronavirus disease 2019 (COVID-19). However, it …
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection
…, J Milligan, C Frenette, TC Lee - JAMA internal …, 2015 - jamanetwork.com
Importance Clostridium difficileinfection (CDI) is associated with significant morbidity, mortality,
and a high risk of recurrence. Proton pump inhibitor (PPI) use is associated with an initial …
and a high risk of recurrence. Proton pump inhibitor (PPI) use is associated with an initial …
Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …
[HTML][HTML] Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
Background Precise estimates of mortality in Staphylococcus aureus bacteraemia (SAB) are
important to convey prognosis and guide the design of interventional studies. Objectives We …
important to convey prognosis and guide the design of interventional studies. Objectives We …
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
…, MA Trabaud, M Fralick, TC Lee… - The Lancet …, 2023 - thelancet.com
Background Interpretation of the evidence from randomised controlled trials (RCTs) of
remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the …
remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the …
Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: a systematic review and meta-analysis
TC Lee, S Vigod, É Bortolussi-Courval… - JAMA network …, 2022 - jamanetwork.com
Importance Widely available and affordable options for the outpatient management of COVID-19
are needed, particularly for therapies that prevent hospitalization. Objective To perform …
are needed, particularly for therapies that prevent hospitalization. Objective To perform …